The top 5 most-watched video interviews of 2021 on AJMC.com addressed myths about COVID-19 vaccination, eye health, and dermatologic conditions, as well as the use of sodium glucose co-transporter 2 (SGLT2) inhibitors in the treatment of type 2 diabetes, chronic kidney disease, and heart failure.
The most-viewed video interviews on AJMC.com for 2021 discussed efficacy findings of sodium glucose co-transporter 2 (SGLT2) inhibitors for the treatment of chronic conditions, and myths about COVID-19 vaccination, and other pandemic about eye health and skin manifestations.
Here are the 5 most-viewed video interviews of 2021:
5. Dr Deepak Bhatt Discusses SCORED, SOLOIST Trial Results
Deepak L. Bhatt, MD, MPH, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital Heart & Vascular Center and professor of medicine at Harvard Medical School, discussed positive findings of the SCORED and SOLOIST trials presented at the American Diabetes Association's (ADA) 81st Scientific Sessions. Both trials demonstrated the safety and efficacy of sotagliflozin, a SGLT2 inhibitor, in the treatment of chronic kidney disease, type 2 diabetes, and heart failure.
4. Dr Rajesh Rajpal on Eye Health Implications of Visual Needs in Younger Populations
In an interview, Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson (J&J) Vision, spoke about the substantial increase of visual needs in recent years and how eye conditions such as cataract have become more consequential at an earlier age. He also mentioned the process of cataract surgery and the different options available for patients in selecting intraocular lenses.
3. Dr William "Andy" Nish Debunks Common Reasons for Not Getting COVID-19 Vaccine
Discussing misconceptions about COVID-19 vaccines, William "Andy" Nish, MD, a medical director and provider with a specialty in allergy and immunology at Northeast Georgia Physicians Group in Gainesville, Georgia, emphasized the importance of getting vaccinated as soon as possible to protect one’s self, family, and community against the risk of infection. He noted that the risk of getting COVID-19 is much higher and much worse than the risks of getting the vaccine even for younger populations who would be considered at low risk of complications.
2. Dr Rajesh Rajpal Reviews Latest Innovations in Cataract Surgery
In another interview, Rajpal spoke further on the latest surgical options available to patients undergoing cataract surgery. He noted that intraocular lenses have now advanced to the point where there are various options that can help patients reduce their need for glasses after cataract surgery. At J&J, Rajpal said their use of the TECNIS family of intraocular lenses provides a wide range of lenses that can fix distance vision specifically or the continuous range of vision.
1. Dr Christine Ko: “COVID Toes” Not Active Skin Infection
Christine Ko, MD, professor of dermatology and pathology at Yale University, addressed skin-related toe manifestations of COVID-19 called perniosis. Dr Ko described perniosis as a discoloration of the skin that mostly affects the toes and can also manifest in other parts of the foot. However, she said that COVID-19 is not an active infection of the skin despite these reported instances.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More